Gabapentin Tablet
Product Images NDC 71335-2281

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 71335-2281). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Gabapentin Equation (Gabapentin Equation)

A formula for calculating creatinine clearance (CLCr) based on age, weight, serum creatinine, and a factor adjustment for female patients. The formula includes multiplication by 0.85 for females.*

FDA Label Image

Gabapentin-fig1 (Gabapentin Fig1)

Line graph depicting mean pain scores over eight weeks comparing Gabapentin 3600 mg/day and placebo. The x-axis shows weeks from baseline through an 8-week period divided into a 4-week dose titration period and a 4-week fixed dose period. The y-axis represents mean pain score, ranging from 0 to 10. Gabapentin shows a decreasing trend in pain scores, while placebo remains relatively stable.*

FDA Label Image

Gabapentin-fig2 (Gabapentin Fig2)

A line graph showing mean pain score over 7 weeks comparing placebo with Gabapentin at doses of 1800 mg/day and 2400 mg/day. The graph includes a 3-week dose titration period followed by a 4-week fixed dose period, illustrating changes in mean pain score from baseline to week 7 for each group.*

FDA Label Image

Gabapentin-fig3 (Gabapentin Fig3)

A bar graph showing the proportion of responders (patients with ≥ 50% reduction in pain score) at endpoint in two controlled PHN studies. Study 1 compares placebo (12%) and Gabapentin 3600 mg (29%). Study 2 compares placebo (14%), Gabapentin 1800 mg (32%), and Gabapentin 2400 mg (34%). Statistical significance is indicated (p<0.01 and p<0.001).*

FDA Label Image

Gabapentin-fig4 (Gabapentin Fig4)

A scatter plot chart displaying percentage difference on the vertical axis and daily dose in milligrams on the horizontal axis. Data points represent results from three different studies labeled as STUDY a, STUDY b, and STUDY c, each plotted at daily doses of 600 mg, 900 mg, 1200 mg, and 1800 mg, showing variation in difference percentage across doses and studies.*

FDA Label Image

Gabapentin-structure (Gabapentin Structure)

Chemical structure diagram of gabapentin showing the molecular arrangement of its atoms, including a cyclohexane ring attached to an amino group and a carboxyl group.*

FDA Label Image

Label (Lbl713352281)

Label for Gabapentin Tablets, USP 600 mg, oral tablets. The label indicates the product contains 500 tablets and is labeled by Bryant Ranch Prepack, manufactured by Alkem Laboratories Ltd. It includes storage instructions and a medication guide URL, with Rx only designation and the NDC number 71335-2281-1.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.